Andrew P. Reeve

Andrew Reeve focuses his practice on white collar and product liability matters at both the state and federal levels. On the product side, Andrew represents pharmaceutical and medical device manufacturers in both individual and mass tort actions.

View the full bio for Andrew P. Reeve at the Faegre Drinker website.

Articles by Andrew P. Reeve:


The Prison Litigation Reform Act – A Product Liability Statute in Disguise

United States prisoners file an inordinate number of often frivolous lawsuits. In federal district courts alone, prisoners filed more than 28,000 last year. With time on their hands, and influenced by plaintiff attorneys’ advertisements and/or sensational media coverage of multimillion-dollar personal injury verdicts, many prisoners pursue baseless product liability actions. Their goal: winning an outsized verdict or, at least, a quick, nuisance-value settlement. They have had little to lose. Yet, defendant pharmaceutical companies are forced to litigate these cases, faced with the attendant costs of often-complicated inmate discovery. Many judges and/or magistrates, perhaps influenced by civil rights concerns, sometimes bend the rules of Civil Procedure for pro se prison plaintiffs. The result: Expensive litigation of often meritless lawsuits with virtually no chance of collecting costs as a prevailing party.

Continue reading “The Prison Litigation Reform Act – A Product Liability Statute in Disguise”

Northern District of California Excludes Expert Testimony and Grants Summary Judgment in Abilify Case

Applying basic scientific principles to exclude an expert’s unfounded and unsupported opinions, the U.S. District Court for the Northern District of California has granted summary judgment to the maker of the antipsychotic medication Abilify on the plaintiff’s failure to warn and negligent design defect claims. Rodman v. Otsuka America Pharmaceutical, Inc., 2020 WL 2525032 (N.D. Cal. May 18, 2020).

Continue reading “Northern District of California Excludes Expert Testimony and Grants Summary Judgment in Abilify Case”